Mabpharm Limited (HK:2181) has released an update.
Mabpharm Limited has scheduled a board meeting for August 28, 2024, where the directors will review and approve the company’s interim financial results for the first half of the year. This key event for stakeholders will also involve other unspecified business transactions. The announcement comes as an essential update for investors tracking the company’s performance.
For further insights into HK:2181 stock, check out TipRanks’ Stock Analysis page.
